Morning Overview on MSN

An SGLT2 pill protected the kidneys of teenagers with type 1 diabetes in a new trial

Teenagers with type 1 diabetes now have the first randomized trial evidence that an SGLT2 inhibitor can protect their kidneys ...
Morning Overview on MSN

A new wearable tracks both blood sugar and ketones from a single sensor

People with diabetes who need to track both glucose and ketone levels have long juggled separate devices, pricking their ...
Medical Dialogues

Study Finds One-Third of ED Patients Diagnosed With DKA Despite Not Meeting Laboratory Criteria

The researchers concluded that emergency physicians often diagnose DKA despite the absence of initial laboratory criteria, ...
note

Explain the mechanism by which SGLT2 inhibitors cause ketoacidosis!

SGLT2 inhibitors can cause ketoacidosis through multiple pathways. A characteristic feature is that it manifests as "euglycemic DKA (EDKA)," where ketoacidosis occurs while blood glucose levels are ...
note

[Expert Commentary] Euglycemic DKA with SGLT2 Inhibitors: Are You Missing It? — The Pitfalls of "Hidden DKA" That Occurs Even with Blood Glucose Below 200

[Expert Commentary] Euglycemic DKA with SGLT2 Inhibitors: Are You Missing It? — The Pitfalls of "Hidden DKA" That Occurs Even with Blood Glucose Below 200 "Doctor, this patient's blood glucose is 180, ...
The American Journal of Managed Care

SGLT2 Inhibitors for Treatment of Heart Failure

Panelists discuss how SGLT2 inhibitors evolved from diabetes medications to become foundational heart failure therapy with class I recommendations across the ejection fraction spectrum, providing ...
The American Journal of Managed Care

SGLT2 Inhibitors Show Protective Effect on Kidneys

SGLT2 inhibitors combat inflammation and slow kidney disease by elevating S-adenosylmethionine (SAM) levels, which suppress inflammatory gene activity through epigenetic modification. The benefits of ...
BMJ

Euglycaemic diabetic ketoacidosis and its risk factors in patients undergoing coronary artery bypass grafting surgery: a single-centre nested case-control study in China

4 Tianjin Key Laboratory of Environment, Nutrition, and Public Health, Tianjin, China 5 Key Laboratory of Prevention and Control of Major Diseases in the Population, Ministry of Education, Tianjin, ...
Managed Healthcare Executive

Sotagliflozin Shows Benefit When Added to Insulin for Type 1 Diabetes

Sotagliflozin added to insulin therapy reduced the risk of hypoglycemia, a potentially life-threatening low-blood-sugar condition, in patients with Type 1 diabetes, according to a post-hoc analysis of ...
Endocrinology Advisor

Preoperative SGLT2 Inhibitor Users Have Increased Risk for Postoperative Euglycemic Ketoacidosis

SGLT2i use was associated with an increased risk for eKA but reduced risks for perioperative AKI and 30-day mortality. HealthDay News — Patients using sodium-glucose cotransporter 2 inhibitors (SGLT2i ...
Too Old to Operate

Preoperative SGLT2 Inhibitor Users Have Increased Risk for Postoperative Euglycemic Ketoacidosis

TUESDAY, May 13, 2025 (HealthDay News) — Patients using sodium-glucose cotransporter 2 inhibitors (SGLT2i) preoperatively have a slightly increased risk for postoperative euglycemic ketoacidosis (eKA) ...
Medscape

Preoperative SGLT2 Use Linked to Lower AKI Risk Post-Surgery

Preoperative use of sodium-glucose cotransporter 2 (SGLT2) inhibitors reduced the risk for acute kidney injury (AKI) by 31% after surgery, according to this retrospective, case-control study. Case ...